AMRX Stock Amneal Pharmaceuticals (AMRX, $12.15) Moving Average Convergence Divergence (MACD) Histogram turned positive on November 24, 2025

GET DAILY SIGNALS

Get AI intraday signals

AMRX - Amneal Pharmaceuticals

MACD signal

View

Odds of UP Trend

Price: $12.15

Daily change: +$0.2 (+1.67%)

Daily volume: 2.6M

Capitalization: $3.8B

Industry: Pharmaceuticals: Generic

This is a Bullish indicator signaling AMRX's price could rise from here. Traders may explore going long the stock or buying call options. A.I. dvisor identified 43 similar cases where AMRX's MACD histogram became positive, and of them led to successful outcomes. Odds of Success:

AMRX's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for AMRX turned positive on November 24, 2025. Looking at past instances where AMRX's MACD turned positive, the stock continued to rise in of 43 cases over the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 21, 2025. You may want to consider a long position or call options on AMRX as a result. In of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where AMRX advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 216 cases where AMRX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMRX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

AMRX broke above its upper Bollinger Band on November 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. AMRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (105.263) is normal, around the industry mean (16.589). AMRX's P/E Ratio (1252.000) is considerably higher than the industry average of (73.316). AMRX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.951). AMRX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (1.366) is also within normal values, averaging (55.567).